Kiromic Biopharma Inc.

09/19/2024 | Press release | Distributed by Public on 09/19/2024 14:40

Kiromic BioPharma Activates the University of Arizona Cancer Center as the Fifth Clinical Trial Site in the Ongoing Phase 1 Deltacel-01 Trial